BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 10146864)

  • 1. The formulary decision-making process in a health maintenance organisation setting.
    Shepherd MD; Salzman RD
    Pharmacoeconomics; 1994 Jan; 5(1):29-38. PubMed ID: 10146864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Operation, formulary decision-making activities of a P & T Committee in a managed care setting.
    Adams J; Richardson J
    Hosp Formul; 1991 Apr; 26(4):291-4, 300-1. PubMed ID: 10109798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of HMO formulary adoption decisions.
    Dranove D; Hughes EF; Shanley M
    Health Serv Res; 2003 Feb; 38(1 Pt 1):169-90. PubMed ID: 12650387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bleeding edge of decision making in managed health care--Kaiser-Permanente's model for formulary development.
    Campen D
    Value Health; 2002; 5(5):383-9. PubMed ID: 12201855
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased pressures change P & T Committee makeup.
    Cross M
    Manag Care; 2001 Dec; 10(12):18-9, 23-4, 27-30. PubMed ID: 11794998
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of relational activities on HMO organizational outcomes.
    Doucette WR
    Am J Manag Care; 1999 Aug; 5(8):1025-34. PubMed ID: 10558126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The formulary decision-making process in a US academic medical centre.
    Nash DB; Catalano ML; Wordell CJ
    Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug product management in health maintenance organizations.
    Kreling DH; Mucha RE
    Am J Hosp Pharm; 1992 Feb; 49(2):374-81. PubMed ID: 1554002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The determinants of HMOs' contracting with hospitals for bypass surgery.
    Gaskin DJ; Escarce JJ; Schulman K; Hadley J
    Health Serv Res; 2002 Aug; 37(4):963-84. PubMed ID: 12236393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation and influence of individuals and committees that decide on drug availability in HMOs.
    Barner JC; Thomas J
    Am J Health Syst Pharm; 1998 Jan; 55(1):56-61. PubMed ID: 9437476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulary-control procedures in a staff-model health maintenance organization.
    Lyon RA
    Am J Hosp Pharm; 1990 Feb; 47(2):340-2. PubMed ID: 2106782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolving use of cost-effectiveness analysis in formulary management within the Department of Veterans Affairs.
    Aspinall SL; Good CB; Glassman PA; Valentino MA
    Med Care; 2005 Jul; 43(7 Suppl):20-6. PubMed ID: 16056005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to use structured decision making in developing therapeutic, cost-effective formulary systems.
    Crane VS
    Hosp Formul; 1993 Oct; 28(10):859-62, 865-7. PubMed ID: 10129135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoeconomics and formulary decision making.
    Sanchez LA
    Pharmacoeconomics; 1996; 9 Suppl 1():16-25. PubMed ID: 10160112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for success in creating an effective multihospital health-system pharmacy and therapeutics committee.
    Leonard MC; Thyagarajan R; Wilson AJ; Sekeres MA
    Am J Health Syst Pharm; 2018 Apr; 75(7):451-455. PubMed ID: 29572313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective decision-making in a changing healthcare environment: a P & T Committee interview.
    Zoloth A; Yon JL; Woolf R
    Hosp Formul; 1989 Feb; 24(2):85-7, 90, 93 passim. PubMed ID: 10291815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The case for a value-based formulary: striving for total lowest net cost.
    Weart W; Bauman GR
    Manag Care Interface; 2007 Apr; 20(4):42-7. PubMed ID: 17474330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating quality of life data into managed care formulary decisions: a case study with salmeterol.
    Bukstein DA
    Am J Manag Care; 1997 Nov; 3(11):1701-6. PubMed ID: 10178468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of pharmacoeconomics to formulary decision making in managed care organizations.
    Suh DC; Okpara IR; Agnese WB; Toscani M
    Am J Manag Care; 2002 Feb; 8(2):161-9. PubMed ID: 11858228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choosing the right PBM.
    Brodsky KL
    HMO; 1995; 36(3):107-9, 112. PubMed ID: 10166470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.